23
Mar

GlaxoSmithKline has reached out to the storied Cold Spring Harbor Laboratory to collaborate on a potential treatment for Type 2 diabetes and obesity, inking a multiyear R&D deal.

…read more

Source: GlaxoSmithKline taps Cold Spring Harbor for diabetes R&D

    

0 No comments